Professor, Psychiatry, University of Iowa College of Medicine
Psychiatry
Dr. Michael A. Flaum, MD
|
|
Give Review
Michael Flaum is an expert in the field of Psychiatry. He attended NYU School of Medicine. He received awards:"Regional Top Doctor". Michael Flaum is a published doctor. He has 82 publications published. The most current publication "Prevalence of depressive symptoms early in the course of schizophrenia." He is registered with Medicare and accepts Medicare payments.
Publications
- Strategies to close the "mortality gap".
- Toward defining schizophrenia as a more useful clinical concept.
- Diagnosing schizophrenia circa 2005: how and why?
- Validity of symptom assessment in psychotic Disorders: information variance across different sources of history.
- Coercion and informed consent in research involving prisoners.
- Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia.
- Older offenders, substance Abuse, and treatment.
- Insomnia as a predictor for symptom worsening following antipsychotic withdrawal in schizophrenia.
- Psychiatric prescribing trends and practices in Iowa's prisons.
- Effects of smoking Marijuana on brain perfusion and cognition.
- Cerebral blood flow changes associated with Schneiderian first-rank symptoms in schizophrenia.
- Effects of olanzapine on cerebellar functional connectivity in schizophrenia measured by fMRI during a simple motor task.
- Anatomic and functional variability: the effects of filter size in group fMRI data analysis.
- Acute Marijuana effects on rCBF and cognition: a PET study.
- Untreated initial psychosis: its relation to quality of life and symptom remission in first-episode schizophrenia.
- Sexual dimorphism in the human brain: evaluation of tissue volume, tissue composition and surface anatomy using magnetic resonance imaging.
- Cognitive correlates of the negative, disorganized, and psychotic symptom dimensions of schizophrenia.
- Defining the phenotype of schizophrenia: cognitive dysmetria and its neural mechanisms.
- Quantitative in vivo measurement of gyrification in the human brain: changes associated with aging.
- Prevalence of Depressive symptoms early in the course of schizophrenia.
- Cerebellar morphology as a predictor of symptom and psychosocial outcome in schizophrenia.
- Two-year outcome in first-episode schizophrenia: predictive value of symptoms for quality of life.
- Morphometry in schizophrenia revisited: height and its relationship to pre-morbid function.
- Psychiatry. More choices for trEating voices.
- Functional MRI statistical software packages: a comparative analysis.
- Incidence of ectopic gray matter in patients with schizophrenia and healthy Control subjects studied with MRI.
- Sex differences in brain morphology in schizophrenia.
- A method to determine activation thresholds in fMRI paradigms.
- Dependence on public financial support early in the course of schizophrenia.
- Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naïve patients.
- Cavum septi pellucidi in normals and patients with schizophrenia as detected by magnetic resonance imaging.
- The Iowa Longitudinal Study of Recent Onset Psychosis: one-year follow-up of first episode patients.
- The life course of schizophrenia: age and symptom dimensions.
- Diagnosis, methodology and subtypes of schizophrenia.
- The core symptoms of schizophrenia.
- Making sense of schizophrenia.
- Suicidal behavior in schizophrenia and its relationship to awareness of illness.
- Racial differences in the diagnosis of psychosis.
- When does Amphetamine-induced psychosis become schizophrenia?
- The deficit syndrome in the DSM-IV Field Trial: I. Alcohol and other drug abuse.
- Soft signs and neuropsychological performance in schizophrenia.
- Brain morphology in first-episode schizophrenia.
- No difference found between winter- and non-winter-born schizophrenic cases.
- The reliability of distinguishing primary versus secondary negative symptoms.
- Premorbid Adjustment as a predictor of phenomenological and neurobiological indices in schizophrenia.
- Symptom dimensions and brain morphology in schizophrenia and related psychotic Disorders.
- Gray matter heterotopias in schizophrenia.
- Symptoms of schizophrenia. Methods, meanings, and mechanisms.
- Effects of diagnosis, laterality, and gender on brain morphology in schizophrenia.
- A longitudinal study of symptom dimensions in schizophrenia. Prediction and patterns of change.
- Spurious precision: procedural validity of diagnostic assessment in psychotic Disorders.
- Neurological soft signs in neuroleptic-naive and neuroleptic-treated schizophrenic patients and in normal comparison subjects.
- Correlational studies of the Scale for the Assessment of Negative Symptoms and the Scale for the Assessment of Positive Symptoms: an overview and update.
- Abnormalities in midline Attentional circuitry in schizophrenia: evidence from magnetic resonance and positron emission tomography.
- Regional brain abnormalities in schizophrenia measured with magnetic resonance imaging.
- Substance abuse in psychotic Disorders: associations with affective syndromes. DSM-IV Field Trial Work Group.
- Stability of cognitive functioning early in the course of schizophrenia.
- Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging.
- Magnetic resonance imaging in familial versus sporadic cases of schizophrenia.
- Awareness of illness in schizophrenia and schizoaffective and mood Disorders.
- Effects of errors in a multicenter medical study: preventing misinterpreted data.
- IQ and brain size in schizophrenia.
- Effect of antipsychotic withdrawal on negative symptoms in schizophrenia.
- Further evidence for olfactory identification Deficits in schizophrenia.
- Epidemiological and clinical correlates of familial and sporadic schizophrenia.
- Techniques for measuring sulcal/gyral patterns in the brain as visualized through magnetic resonance scanning: BRAINPLOT and BRAINMAP.
- Positive and negative symptoms of schizophrenia: past, present, and future.
- Intelligence and brain structure in normal individuals.
- Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the T...
- The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology.
- Comorbidity of substance abuse and schizophrenia: the role of pre-morbid Adjustment.
- The Iowa prospective longitudinal study of recent-onset psychoses.
- Diagnostic criteria for schizophrenia and related Disorders: options for DSM-IV.
- Schizophrenia: the characteristic symptoms.
- The reliability of "bizarre" delusions.
- Ventricular enlargement in schizophrenia evaluated with computed tomographic scanning. Effects of gender, age, and stage of illness.
- The role of gender in studies of ventricle enlargement in schizophrenia: a predominantly male effect.
- Schizophrenia and related psychotic Disorders.
- Ventricular abnormalities in affective Disorder: clinical and demographic correlates.
- Positive and negative symptoms in schizophrenia. A critical reappraisal.
- Neuroleptics and schizophrenia.
Schools
State University of New York Health Science Center At Stony Brook
New York University Med Center
University Ia
Procedures Preformed
- Electroconvulsive Therapy (ECT)
- Group Psychotherapy
- Lithium Therapy (Inpatient Only)
- Psychiatric Evaluation
- View All
Conditions Treated
- Adjustment Disorder
- Alcoholism (Alcohol Dependence)
- Amphetamine and Other Psychostimulant Dependence
- Anorexia
- View All
Doctors Specialties
- Psychiatry
Accepted Insurances
Awards
- Regional Top Doctor
Education
-
University of Iowa Hospitals and Clinics -
NYU School of Medicine -
Stony Brook University School of Medicine
Drug Facts
| NPI NUMBER | 1700872348 | |
| NPPES Provider LastName | FLAUM | |
| NPPES Provider FirstName | MICHAEL | |
| NPPES Provider ZIPCode | 522421009 | |
| NPPES Provider State | IA | |
| Specialty Description | Psychiatry | |
| Total Claim Count | 2677.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1700872348 |
| Last Name Of The Provider | FLAUM |
| First Name Of The Provider | MICHAEL |
| View All |
Similar Doctors
|
|
Dr. Sarah T. Falcon, MD |
|
|
Dr. Peggy C. Nopoulos, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kenji Narushima, MD |
|
|
Dr. Aaron J. Kauer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew E. Segraves, DO |
|
|
Dr. Thomas H. Wassink, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Patricia S. Perrine, MD
This Doctor is OpenDoctor Recommended.
|
|
|
James C. Brown |
|
|
Dr. Sheree L. Murphy, MD
This Doctor is OpenDoctor Recommended.
|